Structured Treatment of Gastroesophageal Reflux in a Company Health Care Setting, -Effect on Quality of Life, Symptoms and Productivity

NCT00884247 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 36

Last updated 2010-12-07

No results posted yet for this study

Summary

The study aims to evaluate if a GERD treatment programme, in accordance with current regional recommendations, in a company health care setting, has an impact on health related quality of life (HRQoL), symptoms, and productivity in GERD patients.

Conditions

  • GERD

Sponsors & Collaborators

Principal Investigators

  • Svante Sjöstedt, MD, PhD · AstraZeneca Sweden

  • Dan Regberg, MD · AstraZeneca Sweden

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-04-30
Completion
2009-06-30

Countries

  • Sweden

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00884247 on ClinicalTrials.gov